Vng-450
VNG-450 contains Valganciclovir 450 mg, an antiviral medication used to treat and prevent cytomegalovirus (CMV) infections in transplant patients.
Key Highlights
- Antiviral CMV Protection
- Treats & Prevents CMV Infections
- Supports Post-Transplant Care
- Helps Protect Immunocompromised Patients
- Effective Valganciclovir 450 mg Formula
Description
VNG-450 contains Valganciclovir 450 mg, an antiviral medication used to treat and prevent cytomegalovirus (CMV) infections, particularly in transplant patients and immunocompromised individuals.
Benefits of VNG-450 Tablet
- Treats cytomegalovirus (CMV) infections effectively.
- Helps prevent CMV infection after organ transplantation.
- Reduces the risk of CMV-related complications.
- Supports recovery in immunocompromised patients.
- Helps control viral replication in the body.
- Protects transplant recipients from severe CMV disease.
- Improves overall management of CMV infections when used as prescribed.
